1.
Some Issues about Meridian Distribution of Traditional Chinese Medicine in Chinese Pharmacopoeia(2005)
对2005年版《中国药典》中药归经一些问题的思考
2.
The determination results of sample were almost identical to those obtained by ChP method.
样品测定结果与中国药典法大致相同。
3.
Antitussive activity comparison of three kinds of Stemonae Radix in Chinese Pharmacopoeia
《中国药典》3种百部的止咳作用比较
4.
Discussion on the Chinese Medical Herbs Preparation in Chinese Pharmacopoeia 2005 Edition
关于《中国药典》2005年版炮制内容的商榷
5.
Consideration on 2005 Edition China Pharmacopoeia from Liangjunjiasu Injection Affair;
由“亮菌甲素”假药案反观2005年版《中国药典》
6.
Discussion on Some Improprieties in The Pharmacopoeia of the People's Republic of China and Clinical Guide to the Chinese Pharmacopoeia
关于《中国药典》及《临床用药须知》不妥之处的讨论
7.
Analysis of Medicinal Substances and Cut Crude Drugs with Forbidding,Contraindication or Caution for Pregnancy in Chinese Pharmacopoeia(2005)
中国药典2005年版药材与饮片妊娠禁用、忌用和慎用药的分析
8.
RESULTS and CONCLUSION The number of vegetable drugs controlled in China pharmacopoeia are obviously less than that in the United States.
结果与结论《中国药典》对重金属和农药残留量的限量要求与《美国药典》相比还有较大差距。
9.
We can provide more than500 kinds of traditional Chinese medicine which meet with CP including raw material, cut, powder.
我公司可提供500余种中国药典标准的中药产品，包括中药材、药饮片、药粉末等。
10.
The problem in Chinese Pharmacopoeia edition 2005 appendix 1
执行《中国药典》2005版一部附录中遇到的问题
11.
Discussing on the function and indication of Traditional Chinese patent Medicine from ChP published in 2005
对2005年版《中国药典》中药成方制剂功能主治一些问题的探讨
12.
The revision advices on quantification of flavonoid aglycones in EGB recorded in ChP
中国药典水解测定银杏黄酮的改进建议
13.
Suggestion on standardizing clinical standard of medicinal materials and cut crude drugs in Chinese Pharmacopoeia 2010 edition
关于规范《中国药典》2010年版药材及饮片临床标准的建议
14.
Discussion on the Detective Markers for Herba Ephedrae in the Chinese Pharmacopoeia
关于《中国药典》中麻黄生物碱含量测定指标的探讨
15.
Modification of the developing agent in thin-layer chromatography
对《中国药典》(2005年版一部)薄层色谱法中部分含苯、甲苯展开剂的改进
16.
Discussing the validation tests for time of adding the tested microorganisms in the microbial limit test described in ChP 2005
2005年版中国药典微生物限度检查法验证试验中加菌时间的探讨
17.
METHODS The detection was carried out according to the principle and procedure in China Pharmacopeia (2000 edition).
方法依照《中国药典》2000年版二部附录的方法和指导原则。
18.
Chinese Pharmacopoeia
《中华人民共和国药典》